Home›People›James Manuso
JM

James Manuso

Director at Opus Genetics. Also a director at TuHURA Biosciences.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Apr 22, 2026·Suggest an edit

About James Manuso

James Manuso is a director at Opus Genetics.

Form D filings name James Manuso as a director at TuHURA Biosciences.

James Manuso reports to the SEC as a director, officer or major shareholder of 4 public companies, including TuHURA Biosciences (HURA), RespireRx Pharmaceuticals (RSPI) and Astex Pharmaceuticals (ASTX).

James Manuso first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name James Manuso in the role, so the role may have started earlier or lasted longer.

Opus Genetics, Inc.
Director
2020 – 2026 · Public company (IRD)
TuHURA Biosciences, Inc.
Director
2023 – 2026 · Public company (HURA)
RespireRx Pharmaceuticals Inc.
President and CEO, director
2015 – 2017 · Public company (RSPI)
Astex Pharmaceuticals, Inc
Chief Executive Officer and director
2006 – 2013 · Public company (ASTX)

Key Colleagues at Startups

The people James Manuso works with at each company, as listed on that company's latest Form D.

TuHURA Biosciences, Inc. · Form D, Dec 27, 2023
PL
DD
Dan Dearborn
Chief Financial Officer
GN
George Ng
Director
AL
Alan List
Director
JB
James Bianco
Executive officer and director
KP
Kiran Patel
Director
ML

Sources

  1. SECTuHURA Biosciences, Inc. Form D, filed Dec 27, 2023
  2. SECForms 3, 4 and 5 filed by James Manuso (SEC filer 1236365)